Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
0.997
+0.030 (3.09%)
At close: Mar 9, 2026, 4:00 PM EDT
0.996
-0.000 (-0.01%)
Pre-market: Mar 10, 2026, 4:00 AM EDT
Heron Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -20.2 | -13.58 | -110.56 | -182.02 | -220.68 | |
| Depreciation & Amortization | 2.31 | 2.49 | 2.9 | 2.89 | 3.02 | |
| Other Amortization | 0.82 | 0.96 | 0.34 | 0.2 | 0.9 | |
| Loss (Gain) From Sale of Assets | - | -0.03 | 0.01 | 0.07 | 0.82 | |
| Asset Writedown & Restructuring Costs | 0.41 | 4.41 | 0.62 | 0.21 | 0.48 | |
| Loss (Gain) From Sale of Investments | -0.74 | -2.14 | -1.74 | -0.74 | 0.33 | |
| Stock-Based Compensation | 10.34 | 12.96 | 32.85 | 42.98 | 46.85 | |
| Other Operating Activities | 11.34 | - | - | - | - | |
| Change in Accounts Receivable | -10.71 | -18.74 | -8.09 | -16.55 | 6.35 | |
| Change in Inventory | -31.05 | -11.05 | 12.46 | -6.19 | -6.48 | |
| Change in Accounts Payable | -2.72 | 8.47 | 0.02 | -0.58 | 3.28 | |
| Change in Other Net Operating Assets | 12.59 | -6.28 | 12.4 | 12.81 | -38.23 | |
| Operating Cash Flow | -27.59 | -22.53 | -58.79 | -146.91 | -203.35 | |
| Capital Expenditures | -0.32 | -1.71 | -1.55 | -1.83 | -3.02 | |
| Sale of Property, Plant & Equipment | 0.1 | 0.03 | 0.01 | 0.23 | 0.03 | |
| Investment in Securities | 16.23 | 20.39 | 19.53 | -1.73 | 35.72 | |
| Investing Cash Flow | 16.01 | 18.71 | 18 | -3.32 | 32.73 | |
| Long-Term Debt Issued | 137.25 | - | 24.35 | - | 148.96 | |
| Total Debt Issued | 137.25 | - | 24.35 | - | 148.96 | |
| Long-Term Debt Repaid | -150 | - | - | - | - | |
| Total Debt Repaid | -150 | - | - | - | - | |
| Net Debt Issued (Repaid) | -12.76 | - | 24.35 | - | 148.96 | |
| Issuance of Common Stock | 19.32 | 0.94 | 30.66 | 76.59 | 7.07 | |
| Other Financing Activities | - | - | -0.9 | -1.53 | - | |
| Financing Cash Flow | 14.43 | 0.94 | 54.11 | 75.06 | 156.03 | |
| Net Cash Flow | 2.85 | -2.88 | 13.31 | -75.18 | -14.6 | |
| Free Cash Flow | -27.91 | -24.24 | -60.33 | -148.74 | -206.38 | |
| Free Cash Flow Margin | -18.02% | -16.80% | -47.49% | -138.14% | -239.01% | |
| Free Cash Flow Per Share | -0.17 | -0.16 | -0.44 | -1.37 | -2.10 | |
| Cash Interest Paid | 6.51 | 4.86 | 3.06 | 2.25 | 1.24 | |
| Levered Free Cash Flow | -28.46 | -25.82 | -16.84 | -75.8 | -103.97 | |
| Unlevered Free Cash Flow | -23.28 | -23.01 | -14.76 | -74.46 | -103.37 | |
| Change in Working Capital | -31.88 | -27.6 | 16.79 | -10.51 | -35.08 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.